« Back
Home /
Rb A' C. botulinum Type E Antibody (1mg)

Rb A' C. botulinum Type E Antibody (1mg)

Item no.	OAMA02828
Manufacturer	AVIVA Systems Biology
Amount	1mg
Category	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Cell Biology Cell Status Western Blot ELISA Senescence Primary Antibodies Astrocytoma By Organ Bladder Cancer Bone Cancer
Type	Antibody Polyclonal
Format	Purified, Liquid
Applications	WB, ELISA
Specific against	other
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Rabbit Antibody to Clostridium botulinum Type E Neurotoxin
Available
Description	Rabbit A' C. botulinum Type E (1mg)
Short description	Aviva Systems Biology is a leading manufacturer of antibodies, proteins, peptides, and accessory reagents. Aviva’s catalog is filled with many unique products. If you need assistance at any time in your searches, please email us at mailto:infohoelzel.de'>infohoelzel.de. Aviva has generated over 5, 000 product categories to assist you when browsing our catalog. Please select the related products tab below to view other relevant reagents. Please review the product specifications below.
Alias symbols	Rabbit Antibody to Clostridium botulinum Type E Neurotoxin
Reconstitution and storage	Store at -20C. Avoid multiple freeze/thaw cycles.
Specificity	Clostridium botulinum Type E Neurotoxin C. botulinum Type E Neurotoxin
Purity	Protein G Sepharose chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 8/30/2024